Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism

Toxicology and Applied Pharmacology

Volumn 217, Issue 3, 2006, Pages 266-276

  Awe, S O ^a   Adeagbo, A S O ^a   D'Souza, S E ^a   Bhatnagar, A ^a   Conklin, D J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Aldehyde; endothelium derived hyperpolarization factor (EDHF); Endothelium derived relaxing factor; eNOS null mice; Ouabain sensitive dilation; Potassium channels

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; 4 HYDROXYNONENAL; 6 (2 PROPARGYLOXYPHENYL)HEXANOIC ACID; ACROLEIN; APAMIN; BUFFER; CIRAZOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEXANOIC ACID; HEXOBARBITAL; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OUABAIN; POTASSIUM; PROPIONALDEHYDE; PYRAZOLE DERIVATIVE; TEMPOL; TETRABUTYLAMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG RELEASE; DRUG SENSITIVITY; MALE; MESENTERY BLOOD VESSEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERFUSION PRESSURE; RAT; SIGNAL PROCESSING; VASODILATATION;

ACROLEIN; ANIMALS; APAMIN; BIOLOGICAL FACTORS; BLOOD VESSELS; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL POLLUTANTS; MALE; MESENTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

RODENTIA; STROPHANTHUS GRATUS;

EID: 33845208768     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.08.008     Document Type: Article

References (68)

1. Adams Jr. J.D., and Klaidman L.K. Acrolein-induced oxygen radical formation. Free Radical Biol. Med. 15 (1993) 187-193
2. Adeagbo A.S., and Malik K.U. Mechanism of vascular actions of prostacyclin in the rat isolated perfused mesenteric arteries. J. Pharmacol. Exp. Ther. 252 (1990) 26-34
3. Adeagbo A.S., and Triggle C.R. Varying extracellular [K+]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21 (1993) 423-429
4. Adeagbo A.S., Awe S.O., Wulff H., and Joshua I.G. Mesenteric arterial dilation induced by 11,12-epoxyeicosatrienoic acid involves BKCa and IKCa channels. FASEB J. 18 (2004) A1281
5. Anderson M.M., Hazen S.L., Hsu F.F., and Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99 (1997) 424-432
6. Archer S.L., Gragasin F.S., Wu X., Wang S., McMurtry S., Kim D.H., Platonov M., Koshal A., Hashimoto K., Campbell W.B., Falck J.R., and Michelakis E.D. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 107 (2003) 769-776
7. Arlt S., Beisiegel U., and Kontush A. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr. Opin. Lipidol. 13 (2002) 289-294
8. Awe S.O., and Adeagbo A.S. Analysis of tert-butyl hydroperoxide induced constrictions of perfused vascular beds in vitro. Life Sci. 71 (2002) 1255-1266
9. Beauchamp Jr. R.O., Andjelkovich D.A., Kligerman A.D., Morgan K.T., and Heck H.D. A critical review of the literature on acrolein toxicity. Crit. Rev. Toxicol. 14 (1985) 309-380
10. Bolz S.S., de Wit C., and Pohl U. Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels. Br. J. Pharmacol. 128 (1999) 124-134
11. Boor P.J., Moslen M.T., and Reynolds E.S. Allylamine cardiotoxicity: I. Sequence of pathologic events. Toxicol. Appl. Pharmacol. 50 (1979) 581-592
12. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23 (2002) 374-380
13. Butterfield D.A., Castegna A., Lauderback C.M., and Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23 (2002) 655-664
14. Calingasan N.Y., Uchida K., and Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72 (1999) 751-756
15. Campbell W.B., Gebremedhin D., Pratt P.F., and Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78 (1996) 415-423
16. Chandra A., and Srivastava S.K. A synthesis of 4-hydroxy-2-trans-nonenal and 4-(3H) 4-hydroxy-2-trans-nonenal. Lipids 32 (1997) 779-782
17. Conklin D.J., Langford S.D., and Boor P.J. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol. Sci. 46 (1998) 386-392
18. Conklin D.J., Boyce C.L., Trent M.B., and Boor P.J. Amine metabolism: a novel path to coronary artery vasospasm. Toxicol. Appl. Pharmacol. 175 (2001) 149-159
19. Conklin D.J., Cowley H.R., Wiechmann R.J., Johnson G.H., Trent M.B., and Boor P.J. Vasoactive effects of methylamine in isolated human blood vessels: role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide. Am. J. Physiol.: Heart Circ. Physiol. 286 (2004) H667-H676
20. Crane G.J., Gallagher N., Dora K.A., and Garland C.J. Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J. Physiol. 553 (2003) 183-189
21. Daimon M., Sugiyama K., Kameda W., Saitoh T., Oizumi T., Hirata A., Yamaguchi H., Ohnuma H., Igarashi M., and Kato T. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr. J. 50 (2003) 61-67
22. Deng C., and Zhang X. A simple, rapid and sensitive method for determination of aldehydes in human blood by gas chromatography/mass spectrometry and solid-phase microextraction with on-fiber derivatization. Rapid Commun. Mass Spectrom. 18 (2004) 1715-1720
23. Egle Jr. J.L., and Hudgins P.M. Dose-dependent sympathomimetic and cardioinhibitory effects of acrolein and formaldehyde in the anesthetized rat. Toxicol. Appl. Pharmacol. 28 (1974) 358-366
24. Feletou M., and Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93 (1988) 515-524
25. Feletou M., and Vanhoutte P.M. The third pathway: endothelium-dependent hyperpolarization. J. Physiol. Pharmacol. 50 (1999) 525-534
26. Feron V.J., Til H.P., de Vrijer F., Woutersen R.A., Cassee F.R., and van Bladeren P.J. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259 (1991) 363-385
27. Fisslthaler B., Popp R., Kiss L., Potente M., Harder D.R., Fleming I., and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 (1999) 493-497
28. Fitzpatrick F.A., and Murphy R.C. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol. Rev. 40 (1988) 229-241
29. Fleming I. Cytochrome p450 and vascular homeostasis. Circ. Res. 89 (2001) 753-762
30. Gahl W.A., and Pitot H.C. Polyamine degradation in foetal and adult bovine serum. Biochem. J. 202 (1982) 603-611
31. Ghilarducci D.P., and Tjeerdema R.S. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144 (1995) 95-146
32. Graier W.F., Hoebel B.G., Paltauf-Doburzynska J., and Kostner G.M. Effects of superoxide anions on endothelial Ca2+ signaling pathways. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1470-1479
33. Green M.A., and Egle Jr. J.L. The effects of acetaldehyde and acrolein on blood pressure in guanethidine-pretreated hypertensive rats. Toxicol. Appl. Pharmacol. 69 (1983) 29-36
34. Grosch W. Reactions of hydroperoxides-products of low molecular weights. In: Chan H.W.S. (Ed). Autoxidation of Unsaturated Lipids (1987), Academic Press, London 95-139
35. Hamilton T.C., and Weston A.H. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen. Pharmacol. 20 (1989) 1-9
36. Huang A., Sun D., Jacobson A., Carroll M.A., Falck J.R., and Kaley G. Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle. Circ. Res. 96 (2005) 376-383
37. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicol. Sci. 57 (2000) 6-15
38. Kwak M.K., Kensler T.W., and Casero Jr. R.A. Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein. Biochem. Biophys. Res. Commun. 305 (2003) 662-670
39. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22 (2001) 187-194
40. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., Kanaide H., and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. 106 (2000) 1521-1530
41. Matoba T., Shimokawa H., Morikawa K., Kubota H., Kunihiro I., Urakami-Harasawa L., Mukai Y., Hirakawa Y., Akaike T., and Takeshita A. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1224-1230
42. Mauban J.R., and Wier W.G. Essential role of EDHF in the initiation and maintenance of adrenergic vasomotion in rat mesenteric arteries. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) H608-H616
43. Medina-Navarro R., Duran-Reyes G., Diaz-Flores M., Hicks J.J., and Kumate J. Glucose-stimulated acrolein production from unsaturated fatty acids. Hum. Exp. Toxicol. 23 (2004) 101-105
44. Minamiyama Y., Takemura S., Toyokuni S., Imaoka S., Funae Y., Hirohashi K., Yoshikawa T., and Okada S. CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radical Biol. Med. 37 (2004) 703-712
45. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J., and Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biol. Med. 33 (2002) 620-626
46. Morikawa K., Shimokawa H., Matoba T., Kubota H., Akaike T., Talukder M.A., Hatanaka M., Fujiki T., Maeda H., Takahashi S., and Takeshita A. Pivotal role of Cu, Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J. Clin. Invest. 112 (2003) 1871-1879
47. Porter N.A., Caldwell S.E., and Mills K.A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30 (1995) 277-290
48. Portoles M.T., Ainaga M.J., and Pagani R. The induction of lipid peroxidation by E. coli lipopolysaccharide on rat hepatocytes as an important factor in the etiology of endotoxic liver damage. Biochim. Biophys. Acta 1158 (1993) 287-292
49. Ren S., Kalhorn T.F., and Slattery J.T. Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein. Drug Metab. Dispos. 27 (1999) 133-137
50. Ren J., Wang G.J., Petrovski P., Ren B.H., and Brown R.A. Influence of hypertension on acetaldehyde-induced vasorelaxation in rat thoracic aorta. Pharmacol. Res. 45 (2002) 195-199
51. Romanko O.P., and Stepp D.W. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the Obese Zucker rat. Am. J. Physiol.: Heart Circ. Physiol. 289 (2005) H2097-H2102
52. Romero F.J., Romero M.J., Bosch-Morell F., Martinez M.C., Medina P., and Lluch S. 4-Hydroxynonenal-induced relaxation of human mesenteric arteries. Free Radical Biol. Med. 23 (1997) 521-523
53. Sakata K., Kashiwagi K., Sharmin S., Ueda S., Irie Y., Murotani N., and Igarashi K. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem. Biophys. Res. Commun. 305 (2003) 143-149
54. Satoh K., Yamada S., Koike Y., Igarashi Y., Toyokuni S., Kumano T., Takahata T., Hayakari M., Tsuchida S., and Uchida K. A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Anal. Biochem. 270 (1999) 323-328
55. Sewerynek E., Melchiorri D., Chen L., and Reiter R.J. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radical Biol. Med. 19 (1995) 903-909
56. Sharmin S., Sakata K., Kashiwagi K., Ueda S., Iwasaki S., Shirahata A., and Igarashi K. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem. Biophys. Res. Commun. 282 (2001) 228-235
57. Suzuki D., and Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern. Med. 38 (1999) 309-314
58. Tani T., Satoh S., and Horiguchi Y. The vasodilator action of formaldehyde in dogs. Toxicol. Appl. Pharmacol. 43 (1978) 493-499
59. Tsakadze N.L., Srivastava S., Awe S.O., Adeagbo A.S., Bhatnagar A., and D'Souza S.E. Acrolein-induced vasomotor responses of rat aorta. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H727-H734
60. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 9 (1999) 109-113
61. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., and Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998) 16058-16066
62. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Noguchi N., Niki E., and Osawa T. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 4882-4887
63. Uesugi N., Sakata N., Nangaku M., Abe M., Horiuchi S., Hisano S., and Iwasaki H. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am. J. Kidney Dis. 44 (2004) 224-238
64. Wang M.H., Brand-Schieber E., Zand B.A., Nguyen X., Falck J.R., Balu N., and Schwartzman M.L. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 284 (1998) 966-973
65. Weston A.H., Richards G.R., Burnham M.P., Feletou M., Vanhoutte P.M., and Edwards G. K+-induced hyperpolarization in rat mesenteric artery: identification, localization and role of Na+/K+-ATPases. Br. J. Pharmacol. 136 (2002) 918-926
66. Woodman O.L., and Boujaoude M. Chronic treatment of male rats with daidzein and 17 beta-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation. Br. J. Pharmacol. 141 (2004) 322-328
67. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276 (2001) 36059-36062
68. Zygmunt P.M., and Hogestatt E.D. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol. 117 (1996) 1600-1606